28th Jan 2014 09:47
LONDON (Alliance News) - Biotechnology company Deltex Medical Group PLC Tuesday said it has entered into a three-year non-exclusive marketing and distribution agreement with Uscom Ltd, the company that manufactures and markets the non-invasive Doppler ultrasound cardiac output monitor, known as the USCOM1A.
Under the agreement, each company will market and distribute each other?s technologies in their developed markets. For Deltex, this means greater access to Asia and Australasia where adoption of CardioQ-ODM is at an early stage.
Deltex Medical also will market the USCOM1A in the UK, and introduce it into its wider distribution channels over the coming months.
The USCOM1A is used primarily in adult and paediatric critical care medicine and has emerging evidence of applications in management of both heart failure and sepsis.
Deltex Medical shares were trading 2.1% lower at 13.10 pence per share Tuesday morning.
By Rowena Harris-Doughty; [email protected]; @rharrisdoughty
Copyright © 2014 Alliance News Limited. All Rights Reserved.
Related Shares:
Deltex Medical